A Preservative-Free Approach - Effects on Dry Eye Signs and Symptoms After Cataract Surgery

• Published in: Clinical ophthalmology (Auckland, N.Z.) Vol. 18; pp. 591 - 604
• Main Authors: Jensen, Per, Nilsen, Christian, Gundersen, Morten, Gundersen, Kjell Gunnar, Potvin, Rick, Gazerani, Parisa, Chen, Xiangjun, Utheim, Tor P, Utheim, Øygunn A
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2024; Dove Medical Press
• Subjects: Bromfenac; Cataract; cataract surgery; corneal fluorescein staining; Dexamethasone; Fluorescein; Hyaluronic acid; Lubrication and lubricants; meibomian gland dysfunction; non-invasive keratograph tear break-up time; ocular surface disease index; Ophthalmic drugs; osmolarity; sign of dry eye; Surface active agents; Surgery; Norway; meibomian gland dysfunction; ocular surface disease index; osmolarity; sign of dry eye; corneal fluorescein staining; cataract surgery; non-invasive keratograph tear break-up time
• ISSN: 1177-5467; 1177-5483; 1177-5483
• DOI: 10.2147/OPTH.S446804

To compare the effect of treatment with preservative-free dexamethasone, NSAIDs and trehalose/hyaluronic acid eye drops with the preservative benzalkonium chloride containing dexamethasone and NSAIDs after cataract surgery in dry versus non-dry eyes. In this prospective randomized intervention study, dry eye tests were performed before and 6 weeks after cataract surgery. Patients were considered as having dry eye, SDE (sign of dry eye), if at least one of the following dry eye tests were abnormal; corneal fluorescein staining (CFS), non-invasive keratograph breakup time (NIKBUT) or tear osmolarity. Patients with SDE were randomly assigned to one of two groups. Group 1 patients were treated with dexamethasone and bromfenac eye drops with the preservative benzalkonium chloride (BAC). Group 2 patients were treated with preservative-free dexamethasone and preservative-free diclofenac, as well as a preservative-free lubricant with trehalose and hyaluronic acid both before and after surgery. Patients with normal tear film status acted as the control group (group 3) and received same treatment as group 1. A total of 215 patients were enrolled six weeks after surgery, the number of patients with SDE decreased significantly in groups 1 and 2 (p <0.001). Subjective symptoms and objective measures including osmolarity, NIKBUT, CFS, and tear film thickness (TFT) improved after surgery, tear production remained unchanged, while corneal sensitivity and meibomian gland dysfunction (MGD) parameters worsened. In the control group with normal tear-film status, SDE increased significantly after the surgery (p <0.001). There were no statistically significant differences in tear film parameters between the three groups after surgery. After cataract surgery, patients with mild to moderate dry eyes may experience improved tear film status and reduced symptoms. However, we found no additional beneficial effect on dry eye parameters with treatment with preservative-free dexamethasone, NSAIDs, and lubricants compared to preservative-containing eye drops.